Shanghai Rendu Valuation

688193 Stock   42.38  0.54  1.26%   
At this time, the company appears to be overvalued. Shanghai Rendu Biote has a current Real Value of USD33.01 per share. The regular price of the company is USD42.38. Our model measures the value of Shanghai Rendu Biote from inspecting the company fundamentals such as Return On Equity of 0.0227, shares outstanding of 40 M, and Operating Margin of 0.03 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book
1.8281
Enterprise Value
B
Enterprise Value Ebitda
48.1209
Price Sales
9.7929
Trailing PE
78.4815
Overvalued
Today
42.38
Please note that Shanghai Rendu's price fluctuation is not too volatile at this time. Calculation of the real value of Shanghai Rendu Biote is based on 3 months time horizon. Increasing Shanghai Rendu's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shanghai Rendu is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shanghai Stock. However, Shanghai Rendu's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  42.38 Real  33.01 Hype  44.4 Naive  40.57
The real value of Shanghai Stock, also known as its intrinsic value, is the underlying worth of Shanghai Rendu Biote Company, which is reflected in its stock price. It is based on Shanghai Rendu's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shanghai Rendu's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
33.01
Real Value
46.62
Upside
Estimating the potential upside or downside of Shanghai Rendu Biotechnology helps investors to forecast how Shanghai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shanghai Rendu more accurately as focusing exclusively on Shanghai Rendu's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
40.9042.3443.77
Details
Hype
Prediction
LowEstimatedHigh
39.5244.4049.28
Details
Naive
Forecast
LowNext ValueHigh
35.6940.5745.45
Details

Shanghai Rendu Cash

640.05 Million

Shanghai Rendu Total Value Analysis

Shanghai Rendu Biotechnology is presently estimated to have takeover price of 1.02 B with market capitalization of 1.72 B, debt of 2.93 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shanghai Rendu fundamentals before making investing decisions based on enterprise value of the company

Shanghai Rendu Investor Information

About 60.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.83. In the past many companies with similar price-to-book ratios have beat the market. Shanghai Rendu Biote last dividend was issued on the 30th of October 2024. Based on the key indicators related to Shanghai Rendu's liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Shanghai Rendu Biotechnology is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.

Shanghai Rendu Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Shanghai suggests not a very effective usage of assets in December.
 
Covid

Shanghai Rendu Ownership Allocation

Shanghai Rendu maintains a total of 40 Million outstanding shares. Shanghai Rendu Biote has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.13 % of Shanghai Rendu outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Shanghai Rendu Profitability Analysis

The company reported the revenue of 164.41 M. Net Income was 8.26 M with profit before overhead, payroll, taxes, and interest of 304.22 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Shanghai Rendu's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Shanghai Rendu and how it compares across the competition.

About Shanghai Rendu Valuation

The stock valuation mechanism determines Shanghai Rendu's current worth on a weekly basis. Our valuation model uses a comparative analysis of Shanghai Rendu. We calculate exposure to Shanghai Rendu's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shanghai Rendu's related companies.
Last ReportedProjected for Next Year
Gross Profit133.8 M182.3 M

Shanghai Rendu Quarterly Retained Earnings

132.96 Million

Complementary Tools for Shanghai Stock analysis

When running Shanghai Rendu's price analysis, check to measure Shanghai Rendu's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rendu is operating at the current time. Most of Shanghai Rendu's value examination focuses on studying past and present price action to predict the probability of Shanghai Rendu's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rendu's price. Additionally, you may evaluate how the addition of Shanghai Rendu to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators